Brian Frenzel is a private investor and advisor to life science companies. His management experience includes co-founding and serving as CEO at Centaur Pharmaceuticals, a neurodegenerative disease pharmaceutical company (acquired by Renovis, NASDAQ:RNVS), Vesta Medical, a medical device company (acquired by Pfizer, NYSE:PFE), Adeza Biomedical, a specialty diagnostics company (NASDAQ:ADZA, acquired by Cytyc, NASDAQ:CYTC), and co-founder and COO/CFO of Genelabs Technologies, a biotechnology company (NASDAQ:GNLB).

Prior to entering the startup company arena, Mr. Frenzel was the Director of Corporate Planning at Syntex Corporation, a Principal at Booz, Allen & Hamilton, a Consultant at the Boston Consulting Group and a Lieutenant in the United States Navy Nuclear Power Program. Mr. Frenzel holds a BS in physics and an MBA from Stanford University.